EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Preclinical Disease or Risk Factor? Alzheimer’s Disease as a Case Study of Changing Conceptualizations of Disease

Maartje H N Schermer

The Journal of Medicine and Philosophy: A Forum for Bioethics and Philosophy of Medicine · 2023

DOI: 10.1093/jmp/jhad009 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Medicine and Philosophy: A Forum for Bioethics and Philosophy of Medicine, 2023. Verfasst von Maartje H N Schermer. Beteiligte Einrichtung: Erasmus MC University Medical Centre, Rotterdam, The Netherlands. Hauptthemen laut MEDLINE: Alzheimer Disease. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Dutch Research Council, Nederlandse Organisatie voor Wetenschappelijk Onderzoek.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer’s Disease (AD) provides an excellent case study to investigate emerging conceptions of health, disease, pre-disease, and risk. Two scientific working groups have recently reconceptualized AD and created a new category of asymptomatic biomarker positive persons, who are either said to have preclinical AD, or to be at risk for AD. This article examines how prominent theories of health and disease would classify this condition: healthy or diseased? Next, the notion of being “at risk”—a state somewhere in-between health and disease—is considered from various angles. It is concluded that medical-scientific developments urge us to let go of dichotomous ways of understanding disease, that the notion of “risk,” conceptualized as an increased chance of getting a symptomatic disease, might be a useful addition to our conceptual framework, and that we should pay more attention to the practical usefulness and implications of the ways in which we draw lines and define concepts.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseHumansConcept FormationBiomarkersRisk Factors

Stichwörter der Autor:innen

Alzheimer’sbiomarkerdisease definitionpragmatic approachrisk factor

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Erasmus MC University Medical Centre, Rotterdam, The Netherlands.

Förderung

  • Dutch Research Council
  • Nederlandse Organisatie voor Wetenschappelijk Onderzoek

Zitieren

APA

Schermer, M. H. N. (2023). Preclinical Disease or Risk Factor? Alzheimer’s Disease as a Case Study of Changing Conceptualizations of Disease. The Journal of Medicine and Philosophy: A Forum for Bioethics and Philosophy of Medicine. https://doi.org/10.1093/jmp/jhad009

Vancouver

Schermer MHN. Preclinical Disease or Risk Factor? Alzheimer’s Disease as a Case Study of Changing Conceptualizations of Disease. The Journal of Medicine and Philosophy: A Forum for Bioethics and Philosophy of Medicine. 2023. doi:10.1093/jmp/jhad009

BibTeX
@article{Schermer2023,
  author = {Schermer, Maartje H N},
  title = {Preclinical Disease or Risk Factor? Alzheimer’s Disease as a Case Study of Changing Conceptualizations of Disease},
  journal = {The Journal of Medicine and Philosophy: A Forum for Bioethics and Philosophy of Medicine},
  year = {2023},
  doi = {10.1093/jmp/jhad009}
}
Kostenlos starten →